ZA93324B - Heterocyclic derivatives - Google Patents

Heterocyclic derivatives

Info

Publication number
ZA93324B
ZA93324B ZA93324A ZA93324A ZA93324B ZA 93324 B ZA93324 B ZA 93324B ZA 93324 A ZA93324 A ZA 93324A ZA 93324 A ZA93324 A ZA 93324A ZA 93324 B ZA93324 B ZA 93324B
Authority
ZA
South Africa
Prior art keywords
heterocyclic derivatives
heterocyclic
derivatives
Prior art date
Application number
ZA93324A
Other languages
English (en)
Inventor
Turuo Oku
Hiroshi Kayakiri
Takayuki Inoue
Akio Kuroda
Hiroyuki Setoi
Shigeki Satoh
Yuki Sawada
Hirokazu Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA93324B publication Critical patent/ZA93324B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA93324A 1992-01-28 1993-01-18 Heterocyclic derivatives ZA93324B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929201789A GB9201789D0 (en) 1992-01-28 1992-01-28 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
ZA93324B true ZA93324B (en) 1993-08-19

Family

ID=10709385

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93324A ZA93324B (en) 1992-01-28 1993-01-18 Heterocyclic derivatives

Country Status (11)

Country Link
EP (1) EP0553682A1 (xx)
JP (1) JP3239506B2 (xx)
KR (1) KR930016423A (xx)
CN (1) CN1077955A (xx)
AU (1) AU3195993A (xx)
CA (1) CA2088220A1 (xx)
GB (1) GB9201789D0 (xx)
HU (1) HUT63415A (xx)
IL (1) IL104471A0 (xx)
MX (1) MX9300423A (xx)
ZA (1) ZA93324B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013666A1 (en) * 1992-12-07 1994-06-23 Eisai Co., Ltd. Process for producing imidazopyridine derivative and intermediate
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008506702A (ja) 2004-07-14 2008-03-06 ピーティーシー セラピューティクス，インコーポレーテッド Ｃ型肝炎を治療するための方法
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7645881B2 (en) 2004-07-22 2010-01-12 Ptc Therapeutics, Inc. Methods for treating hepatitis C
PE20070182A1 (es) 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
CA2663500A1 (en) 2006-09-15 2008-03-20 Schering Corporation Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism
JP2010503677A (ja) 2006-09-15 2010-02-04 シェーリング コーポレイション 脂質代謝の障害を治療するためのアゼチジノン誘導体
CN101541805A (zh) 2006-09-15 2009-09-23 先灵公司 用于治疗疼痛和脂代射紊乱的氮杂环丁烷和氮杂环丁酮衍生物
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5210092A (en) * 1990-09-25 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Angiotensin ii antagonizing heterocyclic derivatives
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
TW274551B (xx) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
CN1077955A (zh) 1993-11-03
JPH05247038A (ja) 1993-09-24
HU9300217D0 (en) 1993-04-28
IL104471A0 (en) 1993-05-13
GB9201789D0 (en) 1992-03-11
KR930016423A (ko) 1993-08-26
JP3239506B2 (ja) 2001-12-17
CA2088220A1 (en) 1993-07-29
MX9300423A (es) 1993-07-01
AU3195993A (en) 1993-07-29
EP0553682A1 (en) 1993-08-04
HUT63415A (en) 1993-08-30

Similar Documents

Publication Publication Date Title
GB9309716D0 (en) Heterocyclic derivatives
IL109451A0 (en) Heterocyclic derivatives
GB9127279D0 (en) Heterocyclic derivatives
GB9125842D0 (en) Heterocyclic derivatives
ZA93324B (en) Heterocyclic derivatives
GB9102804D0 (en) Heterocyclic derivatives
GB9311562D0 (en) Heterocyclic derivatives
EP0519370A3 (en) Heterocyclic derivatives
GB9216783D0 (en) Heterocyclic derivatives
GB9202633D0 (en) Heterocyclic derivatives
GB9204464D0 (en) New heterocyclic derivatives
GB9208387D0 (en) Heterocyclic derivatives
GB9218781D0 (en) Heterocyclic derivatives
GB9221989D0 (en) Heterocyclic derivatives
GB9226574D0 (en) Heterocyclic derivatives
GB9200633D0 (en) Heterocyclic derivatives
GB9218335D0 (en) Heterocyclic derivatives
GB9217366D0 (en) Heterocyclic derivatives
GB9213825D0 (en) Heterocyclic derivatives
GB9208418D0 (en) Heterocyclic derivatives
GB9206421D0 (en) Heterocyclic derivatives
GB9206417D0 (en) Heterocyclic derivatives
GB9204564D0 (en) Heterocyclic derivatives
GB9203809D0 (en) Heterocyclic derivatives
GB9217960D0 (en) Heterocyclic derivatives